Enlivex Ltd. Ordinary Shares (ENLV) is a publicly traded Healthcare sector company. As of May 21, 2026, ENLV trades at $0.71 with a market cap of $168.08M and a P/E ratio of 0.00. ENLV moved +0.54% today. Year to date, ENLV is -9.97%; over the trailing twelve months it is -28.94%. Its 52-week range spans $0.66 to $2.10. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces ENLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ENLV stock?
Hedge funds tracked by Rallies that own ENLV include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enlivex Ltd. Ordinary Shares.
ENLV Key Metrics
Key financial metrics for ENLV
Metric
Value
Price
$0.71
Market Cap
$168.08M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$2.10
52-Week Low
$0.66
Volume
507
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding ENLV
Renaissance Technologies holds 158.99K shares of ENLV, changed +112.59% as of Dec 31, 2024.
Citadel Advisors holds 9.10K shares of ENLV, changed +203.33% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own ENLV include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enlivex Ltd. Ordinary Shares.
Does Rallies show 13F holders for ENLV?
Yes. Rallies tracks hedge fund and 13F ownership data for ENLV, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ENLV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENLV. It does not provide personalized investment advice.
